Prevention of depressive disorders: a brave new world
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
The disease burden of depression is enormous: now reckoned by the World Health Organization (1996) as the fourth leading contributor to the global burden of disease, and increasing to a position of the greatest contributor to illness burden by 2030 in high-income countries. Prevalence is substantial and the incidence is high, almost 50% of prevalence. At the same time, even under a hypothetical regimen of optimal evidence-based care, the burden of depression, measured in years lived with disabilities, can be averted by only about 25%. More precisely, when the interventions are evidence based and when, in addition, the coverage is 100%, the percentage of years lived with disability avoided is about 34%. However, when coverage rates are more realistically 70%, then the percentage of years lived with disability avoided is about 26%. The implication is clear: needed are better treatments, dissemination (especially in low-income countries), and prevention. My colleagues and I at the June, 2009 Pittsburgh Conference on Depression Prevention (see Acknowledgments) think of ‘‘prevention’’ as encompassing both preemption of incident and recurrent episodes of major depression; and protection from the developmental complications of depression. It is important, in other words, to take a long-term and developmental perspective on depression, across the life span, not limiting prevention to new episodes of depression in people who are either depression-naı̈ve (first episodes) or with a previous history (recurrent episodes). The complications of depression include early school dropout, interpersonal problems, increase in both medical comorbidity and medical risk factors over time, worsening of cognitive impairment, impairment of mobility, excess disability, and increased mortality (both from suicide and from the interactions between depression and medical, especially cardiovascular and cerebrovascular, diseases). Depression diminishes both healthspan and life span. The ultimate goal of depression prevention is to protect and enhance both.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bruce, M. L., Ten Have, T. R., Reynolds III, C. F., Katz, I. I., Schulberg, H. C., Mulsant, B. H., Brown, G. K., McAvay, G. J., Pearson, J. L., & Alexopoulos, G. S. (2004) · JAMA · doi:10.1001/jama.291.9.1081 · Cited by 963 · cited 1×
“With respect to prevention as ‘‘protection’’ (prolonging lifespan and healthspan), participation by older primary care patients in evidence-based depression care management strategies (in the PROSPECT study)([8]) has been linked to lower rates of mortality from cancer at 4–5 year follow-up.”
BackgroundAndrews, G., Issakidis, C., Sanderson, K., Corry, J., & Lapsley, H. (2004) · British Journal of Psychiatry · doi:10.1192/bjp.184.6.526 · Cited by 560 · cited 1×
“At the same time, even under a hypothetical regimen of optimal evidence-based care, the burden of depression, measured in years lived with disabilities, can be averted by only about 25%.([3]) More precisely, when the interventions are evidence based and when, in addition, the coverage is 100%, the percentage of years…”
BackgroundMaintenance Treatment of Major Depression in Old Age
Reynolds, C. F., Dew, M. A., Pollock, B. G., Mulsant, B. H., Frank, E., Miller, M. D., Houck, P. R., Mazumdar, S., Butters, M. A., Stack, J. A., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052619 · Cited by 476 · cited 2×
“In the studies cited above, NNT’s in the range of 7–9 are typical for ‘‘preemption’’ and about 4 for ‘‘protection’’ from recurrences.([10]) These estimates of NNTcontrast favorably with an NNTof 21 in four large trials of statins for the prevention of a second myocardial infarction.”
BackgroundSelf-citationPreventing the Onset of Depressive Disorders: A Meta-Analytic Review of Psychological Interventions
Cuijpers, P., van Straten, A., Smit, F., Mihalopoulos, C., & Beekman, A. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2008.07091422 · Cited by 456 · cited 1×
“Participants in these trials received targeted, specific psychosocial interventions such as preventive cognitive behavioral therapy, interpersonal psychotherapy, problem-solving therapy, or bibliotherapy.([7]) With respect to prevention as ‘‘protection’’ (prolonging lifespan and healthspan), participation by older pri…”
Background
Cited by
Irwin, M. R., Carrillo, C., Sadeghi, N., Bjurstrom, M. F., Breen, E. C., & Olmstead, R. (2022) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2021.3422 · Cited by 203
Sleep disturbance, inflammation and depression risk in cancer survivors
Irwin, M. R., Olmstead, R. E., Ganz, P. A., & Haque, R. (2013) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2012.05.002 · Cited by 173
Reynolds, C. F., Cuijpers, P., Patel, V., Cohen, A., Dias, A., Chowdhary, N., Okereke, O. I., Amanda Dew, M., Anderson, S. J., Mazumdar, S., et al. (2012) · Annual Review of Public Health · doi:10.1146/annurev-publhealth-031811-124544 · Cited by 163
Self-citationArt therapy as an adjuvant treatment for depression in elderly women: a randomized controlled trial
Ciasca, E. C., Ferreira, R. C., Santana, C. L. A., Forlenza, O. V., dos Santos, G. D., Brum, P. S., & Nunes, P. V. (2018) · Revista Brasileira de Psiquiatria · doi:10.1590/1516-4446-2017-2250 · Cited by 123
Topper, M., Emmelkamp, P. M. G., & Ehring, T. (2010) · Applied and Preventive Psychology · doi:10.1016/j.appsy.2012.03.001 · Cited by 95
Metadata
- Authors
- Reynolds, C. F.
- Venue
- Depression and Anxiety
- Publisher
- Hindawi Limited
- Published
- 2009-12
- Volume
- 26
- Issue
- 12
- Pages
- 1062-1065
- ISSN
- 1091-4269 (ISSN-L)
- 1520-6394
- OpenAlex
- W2167541177
- Cited by
- 30
- References
- 4
- FWCI
- 3.79
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.